Prof. Siren SEZER - Medicana Health Group

EDUCATION & EXPERIENCE

Medical School

Hacettepe University Medical Faculty, 1989

Post-Graduate Training

Dates and Places of Education Levels
Ankara University Medical Faculty 1995
Nephrology Diseases Specialty Education
Başkent University Medical Faculty 2000
Assoc. Prof. of Nephrology – Internal Medicine (2002)
Internal Medicine Prof. Dr (2009-2018 Başkent University Internal Medicine Department)

Professional Experience

Internal Medicine (Nephrology) Assoc. Prof. (2002)

Internal Medicine (Prof) Dr (2009-2018 Başkent Üniversitesinde İç Hastalıkları Anabilim Dalı)

Medical Interests

Hypertension acute and chronic renal diseases

Kidney transplantation

Nephritis

Urinary tract infection

Kidney Calculus

Dialysis

Edema

Fluid electrolyte balance

Renal cyst

Congenital renal diseases

Osteoporosis

Diabetic renal disease

Nutrition in chronic diseases

Special Experience

Kidney transplantation

DialysisRegulation of blood pressure

Follow-up of acute chronic kidney patients

Scientific Publications

Articles published in international peer-reviewed journals (SCI,SSCI,Arts and Humanities)

1) Dietary Fiber Intake: Its Relation With Glycation End Products and Arterial Stiffness in End-Stage Renal Disease Patients.
Demirci BG, Tutal E, Eminsoy IO, Kulah E, Sezer S. J Ren Nutr. 2018 Oct 9 doi: 10.1053/j.jrn.2018.08.007
2) Fragmented QRS on 12-Lead Electrocardiogram Is Correlated With Severe Coronary Artery Disease and Abnormal Myocardial Perfusion Scintigraphy Results in Renal Transplant Candidates. Çiftci O, Keskin S, Karaçağlar E, Yılmaz KC, Aktaş A, Sezer S, Moray G, Müderrisoğlu İH, Haberal M. Exp Clin Transplant. 2018 Jul 31. doi: 10.6002/ect.2017.026
3) Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients. Bal Z, Demirci BG, Karakose S, Tutal E, Erkmen Uyar M, Acar NO, Sezer S. ScientificWorldJournal. 2018 Apr 1;2018:8065691. doi: 10.1155/2018/8065691
4) FGF23, NGAL, and Endostatin: the Predictors of Allograft Function in Renal Transplant Recipients. Gürlek Demirci B, Sezer S, Uyanık Yıldırım S, Kaynar Erdoğan M, Tutal E, Özdemir Ö, Orazbayev G, Haberal M. Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):136-139. doi: 10.6002/ect.
5) Hand-Grip Strength Is Associated With Serum Testosterone and Albumin Levels in Male Kidney Transplant Recipients.
Gürlek Demirci B, Sezer S, Tutal E, Çolak T, Uyanık S, Haberal M. Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):75-79. doi: 10.6002/ect.
6) Mediterranean diet as the diet of choice for patients with chronic kidney disease. Chauveau P, Aparicio M, Bellizzi V, Campbell K, Hong X, Johansson L, Kolko A, Molina P, Sezer S, Wanner C, Ter Wee PM, Teta D, Fouque D, Carrero JJ; European Renal Nutrition (ERN) Working Group of the European Renal Association–European Dialysis Transplant Association (ERA-EDTA). Nephrol Dial Transplant. 2018 May 1;33(5):725-735. doi: 10.1093/ndt/gfx085
7) Preoperative Cardiac Risk Assessment in Renal Transplant Recipients: A Single-Center Experience. Yilmaz KC, Akgün AN, Ciftci O, Muderrisoglu H, Sezer S, Moray G, Haberal M. Exp Clin Transplant. 2017 Oct 12. doi: 10.6002/ect.2017.0145
8) Blood Pressure and Age Are the Main Determinants of Aortic Stiffness. Güçlü A, Nar G, İçli A, Özhan N, Sezer S.
Med Princ Pract. 2017;26(5):496. doi: 10.1159/000480440
9) Peripheral Muscle Strength Indicates Respiratory Function Testing in Renal Recipients. Ulubay G, Uyanik S, Er Dedekarginoglu B, Serifoglu I, Kupeli E, Savas Bozbas S, Sezer S, Haberal M. Exp Clin Transplant. 2017 Feb;15(Suppl 1):249-253. PMID:28260479
10) The role of phosphate in kidney disease. Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D; ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group. Nat Rev Nephrol. 2017 Jan;13(1):27-38. doi: 10.1038/nrneph.2016.
11) Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients. Uyar ME, Yucel P, Ilin S, Bal Z, Yildirim S, Uyar AS, Akay T, Tutal E, Sezer S. Cardiovasc J Afr. 2016 May/Jun;27(3):128-133. doi: 10.5830/CVJA-2015-051
12) Effect of Smoking on Peripheral Blood Lymphocyte Subsets of Patients With Chronic Renal Failure. Düvenci Birben Ö, Akçay Ş, Sezer S, Şirvan Ş, Haberal M. Exp Clin Transplant. 2016 Nov;14(Suppl 3):91-94. PMID:27805522
13) Role of Procalcitonin in Differential Diagnosis of Pneumonia and Pulmonary Congestion Associated With End-Stage Renal Failure.Akçay Ş, Doğrul I, Sezer S, Haberal M.Exp Clin Transplant. 2016 Nov;14(Suppl 3):71-73. PMID:27805517
14) Relationship between Fragmented QRS Complex and Aortic Stiffness in Chronic Hemodialysis Patients.
Güçlü A, Nar G, İçli A, Özhan N, Sezer S. Med Princ Pract. 2017;26(1):66-70. doi: 10.1159/000452418
15) The effect of hemodialysis on balance measurements and risk of fall. Erken E, Ozelsancak R, Sahin S, Yılmaz EE, Torun D, Leblebici B, Kuyucu YE, Sezer S. Int Urol Nephrol. 2016 Oct;48(10):1705-11. doi: 10.1007/s11255-016-1388-7.
16) As we grow old: nutritional considerations for older patients on dialysis. Johansson L, Fouque D, Bellizzi V, Chauveau P, Kolko A, Molina P, Sezer S, Ter Wee PM, Teta D, Carrero JJ; European Renal Nutrition (ERN) Working Group of the European Renal Association–European Dialysis Transplant Association (ERA-EDTA). Nephrol Dial Transplant. 2017 Jul 1;32(7):1127-1136. doi: 10.1093/ndt/gfw201
17) Hematological parameters can predict the extent of coronary artery disease in patients with end-stage renal disease.Bal Z, Bal U, Okyay K, Yilmaz M, Balcioglu S, Turgay O, Hasirci S, Aydinalp A, Yildirir A, Sezer S, Muderrisoglu H.Int Urol Nephrol. 2015 Oct;47(10):1719-25. doi: 10.1007/s11255-015-1073-2
18) Pulmonary hypertension is closely related to arterial stiffness in renal transplant patients. Bal Z, Sezer S, Uyar ME, Bal U, Kulah E, Guliyev O, Tutal E, Haberal M. Transplant Proc. 2015 May;47(4):1186-9. doi: 10.1016
19) Graft function and arterial stiffness: can bioimpedance analysis be useful in renal transplant recipients? Sezer S, Gurlek Demirci B, Guliyev O, Sayin CB, Colak T, Ozdemir Acar FN, Haberal M. Transplant Proc. 2015 May;47(4):1182-5. doi: 10.1016/j
20) Post-transplantation Anemia Predicts Cardiovascular Morbidity and Poor Graft Function in Kidney Transplant Recipients.
Gurlek Demirci B, Sezer S, Sayin CB, Tutal E, Uyar ME, Ozdemir Acar FN, Haberal M. Transplant Proc. 2015 May;47(4):1178-81. doi: 10.1016/
21) Post-transplant C-reactive protein predicts arterial stiffness and graft function in renal transplant recipients. Gurlek Demirci B, Sezer S, Colak T, Sayin CB, Tutal E, Haberal M. Transplant Proc. 2015 May;47(4):1174-7. doi: 10.1016/j
22) High-grade proteinuria as a cardiovascular risk factor in renal transplant recipients. Guliyev O, Sayin B, Uyar ME, Genctoy G, Sezer S, Bal Z, Demirci BG, Haberal M. Transplant Proc. 2015 May;47(4):1170-3. doi: 10.1016/
23) Hyperviscosity in renal transplant recipients. Tutal E, Erkmen Uyar M, Uyanik S, Bal Z, Guliyev O, Toprak SK, Ilhan O, Sezer S, Haberal M.Transplant Proc. 2015 May;47(4):1165-9. doi: 10.1016
24) Sagittal abdominal diameter as an anthropometric measure of cardiovascular and graft loss risk in renal transplant recipients. Bal Z, Uyar ME, Tutal E, Guliyev O, Colak T, Sezer S, Haberal M. Transplant Proc. 2015 May;47(4):1162-4. doi: 10.1016/
25) Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor. Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Tutal E, Kulah E, Genctoy G, Ozdemir Acar N, Haberal M. Transplant Proc. 2015 May;47(4):1146-51. doi: 10.1016/
26) Fibromyalgia and its clinical relevance in renal transplant recipients. Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Tutal E, Genctoy G, Kulah E, Ozdemir Acar N, Haberal M. Transplant Proc. 2015 May;47(4):1105-9. doi: 10.1016/
27) New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients. Sezer S, Erkmen Uyar M, Tutal E, Bal Z, Guliyev O, Colak T, Hasdemir E, Haberal M. J Diabetes Res. 2015;2015:293896. doi: 10.1155/2015/293896
28) New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients. Sezer S, Erkmen Uyar M, Tutal E, Bal Z, Guliyev O, Colak T, Hasdemir E, Haberal M. J Diabetes Res. 2015;2015:293896. doi: 10.1155/2015/293896
29) Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M, Yilmaz ME, Altun B, Duranay M, Yildiz A, Sahin I, Dogukan A, Ustundag S, Karayaylali I, Kahveci A, Sindel S, Kiykim AA, Yenicerioglu Y, Akbas E, Ozdener F. Clin Kidney J. 2014 Oct;7(5):464-9. doi: 10.1093/ckj/sfu079.
30) Relationship between inflammation and sex hormone profile in female patients receiving different types of renal replacement therapy.Altunoglu A, Yavuz D, Canoz MB, Yavuz R, Karakaş LA, Bayraktar N, Colak T, Sezer S, Ozdemir FN, Haberal M.Transplant Proc. 2014 Jun;46(5):1585-90. doi: 10.1016
31) Increased frequency of gallbladder stone and related parameters in hemodialysis patients. Gençtoy G, Ayidağa S, Ergun T, Lakadamyalı H, Erbayrak M, Sezer S. Turk J Gastroenterol. 2014 Feb;25(1):54-8. doi: 10.5152/tjg.2014.4854
32) Free triiodothyronine in hemodialysis patients: link with malnutrition and inflammation. Yavuz D, Sezer S, Yavuz R, Canoz MB, Altunoglu A, Elsürer R, Arat Z, Ozdemir FN. Iran J Kidney Dis. 2014 May;8(3):212-7. Erratum in: Iran J Kidney Dis. 2014 Jul;8(4):350
33) Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia.Sezer S, Karakan S, Atesagaoglu B, Acar FN. Saudi J Kidney Dis Transpl. 2014 Mar;25(2):316 -20.PMID :2462 5 997
34) Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients. Sezer S, Tutal E, Bal Z, Uyar ME, Bal U, Cakir U, Acar NO, Haberal M. Int J Artif Organs. 2014 Feb;37(2):118-25. doi: 10.5301 /ijao. 500 0289
35) Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis.Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. JPEN J Parenter Enteral Nutr. 2014 Nov;38(8):960-5. doi: 10.1177/0148607113517266.
36) Accumulation of an endogenous inhibitor of nitric oxide synthesis and oxidative DNA damage in end-stage renal disease.Hacişevki A, Gönenç A, Sezer S, Karakan S, Simşek B, Torun M.Clin Lab. 2013;59(11-12):1353-61. PMID:24409671
37) Endothelial nitric oxide synthase polymorphism influences renal allograft outcome. Uyar M, Sezer S, Ozdemir FN, Kulah E, Arat Z, Atac FB, Haberal M. Clin Transplant. 2014 Feb;28(2):223-8. doi: 10.1111/ctr.12302.
38) Cytomegalovirus infection in renal transplant recipients: one center's experience. Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S, Haberal M. Transplant Proc. 2013;45(10):3520-3. doi: 10.1016/j.
39) Body composition analysis of patients on waiting list for cadaveric renal transplantation: a comparison of hemodialysis and peritoneal dialysis patients. Bal Z, Uyar ME, Tutal E, Guliyev O, Sezer S, Haberal M. Transplant Proc. 2013;45(10):3489-93. doi: 10.1016/j
40) Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of hemodialysis patients - a comparison with Mini Nutritional Assessment. Erdoğan E, Tutal E, Uyar ME, Bal Z, Demirci BG, Sayın B, Sezer S. Transplant Proc. 2013;45(10):3485-8. doi: 10.1016
41) Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels. Uyar ME, Tutal E, Bal Z, Sezer S. Transplant Proc. 2013;45(10):3481-4. doi: 10.1016/
42) rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients. Erkmen Uyar M, Toprak SK, Saglam H, Tutal E, Bay M, Ilhan O, Bal Z, Sezer S. Scientific World Journal. 2013 Sep 30;2013:792698. doi: 10.1155/2013/792698
43) The influence of socioeconomic factors on depression in maintenance hemodialysis patients and their caregivers.
Sezer S, Uyar ME, Bal Z, Tutal E, Ozdemir Acar FN. Clin Nephrol. 2013 Nov;80(5):342-8. doi: 10.5414/CN107742
44) The relationship between serum fetuin-A, cystatin-C levels, and microalbuminuria in patients with metabolic syndrome.
Huddam B, Azak A, Koçak G, Bayraktar N, Sezer S. J Clin Lab Anal. 2013 Jul;27(4):317-22. doi: 10.1002/jcla.2160
45) Comparison of preemptive kidney transplant recipients with nonpreemptive kidney recipients in single center: 5 years of follow-up.Sayin B, Colak T, Tutal E, Sezer S. Int J Nephrol Renovasc Dis. 2013 May 29;6:95-9. doi: 10.2147/IJNRD.S42042
46) Left ventricular mass index and its relationship to ambulatory blood pressure and renal resistivity index in renal transplant recipients.Sezer S, Uyar ME, Colak T, Bal Z, Tutal E, Kalaci G, Acar FN. Transplant Proc. 2013 May;45(4):1575-8. doi: 10.1016
47) Evaluation of nutritional status in renal transplant recipients in accordance with changes in graft function. Tutal E, Sezer S, Uyar ME, Bal Z, Demirci BG, Acar FN. Transplant Proc. 2013 May;45(4):1418-22. doi: 10.1016/
48) Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients? Tutal E, Sayın B, Ertugrul DT, Ibis A, Sezer S, Ozdemir N. Int J Nephrol Renovasc Dis. 2013 Apr 26;6:71-7. doi: 10.2147/IJNRD.S41384
49) Early renal transplantation after donor renal angiography affects initial graft function.Tutal E, Canver B, Can S, Colak T, Sezer S, Haberal M. Transplant Proc. 2012 Jun;44(5):1227-30. doi: 10.1016
50) The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
Karakan S, Sezer S, Özdemir Acar FN, Haberal M. Ren Fail. 2012;34(6):732-7. doi: 10.3109/0886022X.2012.676493
51) Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients. Sezer S, Karakan S, Ozdemir N. Ren Fail. 2012;34(4):454-9. doi: 10.3109/0886022X.2012.656562
52) Association of conicity index and renal progression in pre-dialysis chronic kidney disease. Sezer S, Karakan S, Acar NÖ.
Ren Fail. 2012;34(2):165-70. doi: 10.3109/0886022X.2011
53) Body fat percentage as a risk factor for atherosclerosis but not for inflammation for hemodialysis patients: differences between genders. Sezer S, Karakan S, Saşak G, Tutal E, Ozdemir Acar FN. J Ren Nutr. 2012 Sep;22(5):490-8. doi: 10.1053/j.jrn.2011.09.001
54) Daytime sleepiness and quality of life in peritoneal dialysis patients. Bilgic A, Akman B, Sezer S, Arat Z, Ozelsancak R, Ozdemir N. Ther Apher Dial. 2011 Dec;15(6):565-71. doi: 10.1111
55) Factors related to fatigue and subgroups of fatigue in patients with end-stage renal disease. Karakan S, Sezer S, Ozdemir FN. Clin Nephrol. 2011 Nov;76(5):358-64.PMID:22000555
56) Risk factors for kidney impairment and differential impact of liver transplantation on renal function. Sezer S, Karakan S, Erişmiş B, Çolak T, Haberal M. Transplant Proc. 2011 Mar;43(2):609-11. doi: 10.1016/j.transproceed.2011.01.045
57) Factors associated with insulin resistance after long-term renal transplantation.Saşak G, Sezer S, Çolak T, Acar FN, Haberal M. Transplant Proc. 2011 Mar;43(2):575-7. doi: 10.1016/j.transproceed.2011.01.047
58) Circulating levels of osteopontin are related with calcification parameters in patients with renal transplantations. Karakan S, Sezer S, Özdemir Acar FN, Haberal M. Transplant Proc. 2011 Mar;43(2):562-4. doi: 10.1016/j.
59) Nocturnal nondipping hypertension is related to dyslipidemia and increased renal resistivity index in renal transplant patients. Sezer S, Karakan S, Çolak T, Haberal M. Transplant Proc. 2011 Mar;43(2):530-2. doi: 10.1016/
60) The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts.
Özdemir BH, Özdemir AA, Colak T, Sezer S, Haberal M. Transplant Proc. 2011 Mar;43(2):527-9. doi: 10.1016/j.
61) Influence of 1,25-dihydroxyvitamin D3 on human leukocyte antigen-DR expression, macrophage infiltration, and graft survival in renal allografts. Özdemir BH, Özdemir AA, Sezer S, Çolak T, Haberal M. Transplant Proc. 2011 Mar;43(2):500-3. doi: 10.1016
62) Dialysis as a bridge therapy to renal transplantation: comparison of graft outcomes according to mode of dialysis treatment. Sezer S, Karakan S, Özdemir Acar FN, Haberal M. Transplant Proc. 2011 Mar;43(2):485-7. doi: 10.1016/
63) Pretransplantation serum FT3 concentration in kidney recipients is useful to identify higher risk of graft failure.
Karakan S, Sezer S, Ozdemir FN, Haberal M. Transplant Proc. 2011 Mar;43(2):448-50. doi: 10.1016
64) Association between "Malnutrition Inflammation Score" and airway obstruction in patients awaiting renal transplantation: a preliminary study. Ulubay G, Kupeli E, Karakan S, Ozyurek BA, Er B, Bayram ES, Sezer S, Haberal M.
Transplant Proc. 2011 Mar;43(2):441-4. doi: 10.1016
65) The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients. Tutal E, Sezer S, Ibis A, Bilgic A, Ozdemir N, Aldemir D, Haberal M. Transplant Proc. 2010 Jun;42(5):1629-36. doi: 10.1016
66) Nondipping phenomenon and quality of life: are they related in essential hypertensive patients?Afsar B, Elsurer R, Sezer S, Ozdemir FN. Clin Exp Hypertens. 2010 Jan;32(2):105-12. doi: 10.3109/10641960902993137
67) Peritoneal cells at admission: do they have prognostic significance in peritonitis? Elsurer R, Afsar B, Sezer S, Ozdemir FN. Ren Fail. 2010 Jan;32(3):335-42. doi: 10.3109/08860221003611679
68) Regular lactulose use is associated with lower peritonitis rates: an observational study. Afsar B, Elsurer R, Bilgic A, Sezer S, Ozdemir F. Perit Dial Int. 2010 Mar-Apr;30(2):243-6. doi: 10.3747/pdi.2009.00035
69) Factors related to silent myocardial damage in hemodialysis patients. Afsar B, Elsurer R, Akgul A, Sezer S, Ozdemir FN.
Ren Fail. 2009;31(10):933-41. doi: 10.3109/0886022090321613
70) Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis.
Elsurer R, Afsar B, Sezer S, Ozdemir FN, Haberal M. Nephrology (Carlton). 2009 Dec;14(8):712-5. doi: 10.1111/j.1440-1797.2009.01103
71) Relationship between renal resistive index and inflammation in untreated hypertensive patients. Ozelsancak R, Torun D, Koc Z, Sezer S, Ozdemir FN, Niron EA. Int Heart J. 2009 Nov;50(6):753-61.PMID:19952472
72) Insulin resistance is associated with increased renal resistive index independent of other factors in newly diagnosed type 2 diabetes mellitus and hypertensive patients. Afsar B, Elsurer R, Sezer S, Ozdemir FN. Metabolism. 2010 Feb;59(2):279-84. doi: 10.1016/j.metabol.2009.07.025.
73) Vitamin D status, bone mineral density, and inflammation in kidney transplantation patients. Sezer S, Yavuz D, Canoz MB, Ozdemir FN, Haberal M. Transplant Proc. 2009 Sep;41(7):2823-5. doi: 10.1016
74) Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients. Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M. Transplant Proc. 2009 Jun;41(5):1604-8. doi: 10.101
75) Does metabolic syndrome have an impact on the quality of life and mood of hemodialysis patients? Afsar B, Elsurer R, Sezer S, Ozdemir NF. J Ren Nutr. 2009 Sep;19(5):365-71. doi: 10.1053/j.jrn.2009.01.016
76) Quality of life in hemodialysis patients: hepatitis C virus infection makes sense. Afsar B, Elsurer R, Sezer S, Ozdemir NF.
Int Urol Nephrol. 2009 Dec;41(4):1011-9. doi: 10.1007/s11255-009-9576-3
77) Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN. Ren Fail. 2009;31(3):196-200. doi: 10.1080/ 0886022080266 9826
78) Characteristics and outcomes of end-stage renal disease patients with active tuberculosis followed in intensive care units.Ulasli SS, Ulubay G, Arslan NG, Sezer S, Akcay S, Eyuboglu FO, Haberal M. Saudi J Kidney Dis Transpl. 2009 Mar; 20(2): 254-9.PMID:19237814
79) Quality of life is not related with liver disease severity but with anemia, malnutrition, and depression in HCV-infected hemodialysis patients.Afsar B, Ozdemir NF, Sezer S, Haberal M. Hemodial Int. 2009 Jan;13(1):62-71. doi: 10.1111/j.1542-4758.2009.00329
80) Early assessment of renal resistance index and long-term renal function in renal transplant recipients. Akgul A, Ibis A, Sezer S, Basaran C, Usluogullari A, Ozdemir FN, Arat Z, Haberal M. Ren Fail. 2009;31(1):18-24. doi: 10.1080/088602208025 46347
81) Renal resistive index and nocturnal non-dipping: is there an association in essential hypertension? Afsar B, Ozdemir NF, Elsurer R, Sezer S. Int Urol Nephrol. 2009;41(2):383-91. doi: 10.1007/s11255-008-9455-
82) Uric acid and nocturnal nondipping in hypertensive patients with normal renal function. Afsar B, Elsurer R, Ozdemir FN, Sezer S. J Nephrol. 2008 May-Jun;21(3):406-11
83) Determination of the impact of hepatitis C virus on insulin resistance and arterial stiffness in hemodialysis patients.
Adam FU, Torun D, Yigit F, Ozelsancak R, Sezer S, Ozdemir FN, Haberal M. Ren Fail. 2008;30(4):411-5. doi: 10.1080/ 08860 220801985850
84) Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Akgul A, Bilgic A, Sezer S, Arat Z, Ozdemir FN, Haberal M. J Ren Nutr. 2008 Jul;18(4):338-46. doi: 10.1053/j.jrn.2007.11.007
85) Evaluation of coronary microvascular function in patients with end-stage renal disease, and renal allograft recipients. Bozbas H, Pirat B, Demirtas S, Simşek V, Yildirir A, Sade E, Sayin B, Sezer S, Karakayali H, Muderrisoglu H.Atherosclerosis. 2009 Feb;202(2):498-504. doi: 10.1016/j.atherosclerosis.2008.04.043.
86) Predictors for quality of life in continuous ambulatory peritoneal dialysis patients.Bilgic A, Akman B, Sezer S, Ozisik L, Arat Z, Ozdemir FN, Haberal M. Nephrology (Carlton). 2008 Oct;13(7):587-92. doi: 10.1111/j.1440-1797.2008.00970
87) Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.Turhan S, Sezer S, Erden G, Guctekin A, Ucar F, Ginis Z, Ozturk O, Bingol S. Ann Saudi Med. 2008 Mar-Apr;28(2):96-101.PMID: 18474928
88) Malnutrition-inflammation score in peritoneal dialysis: growing reliability. Afsar B, Sezer S, Elsurer R, Ozdemir NF.
Perit Dial Int. 2008 Mar-Apr;28(2):207. No abstract available.PMID18332464
89) Tuberculosis in patients with end-stage renal disease undergoing dialysis in an endemic region of Turkey.
Sen N, Turunc T, Karatasli M, Sezer S, Demiroglu YZ, Oner Eyuboglu F. Transplant Proc. 2008 Jan-Feb;40(1):81-4. doi: 10.1016/j.transproceed.2007.12.003.
90) The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension. Torun D, Ozelsancak R, Turan I, Micozkadioglu H, Sezer S, Ozdemir FN. Int Heart J. 2007 Nov;48(6):733-41.PMID:18160765
91) Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".Tutal E, Sezer S, Bilgic A, Aldemir D, Turkoglu S, Demirel O, Ozdemir N, Haberal M. Transplant Proc. 2007 Dec;39(10):3035-40.PMID:18089316
92) Mortality risk factors in chronic renal failure patients after coronary artery bypass grafting. Akman B, Bilgic A, Sasak G, Sezer S, Sezgin A, Arat Z, Ozdemir FN, Haberal M.Ren Fail. 2007;29(7):823-8.PMID:17994450
93) Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. J Ren Nutr. 2007 Nov;17(6):381-8.PMID:17971310
94) Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.Sezer S, Elsurer R, Afsar B, Arat Z, Ozdemir NF, Haberal M. Nephron Clin Pract. 2007;107(4):c156-62. Epub 2007 Oct 23.PMID:17957127
95) Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients.Elsurer R, Afsar B, Sezer S, Arat Z, Ozdemir FN, Haberal M. Eur J Clin Nutr. 2008 Dec;62(12):1449-54. Epub 2007 Aug 1.PMID:17671439
96) Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.Ozdemir BH, Ozdemir FN, Sezer S, Haberal M. Ren Fail. 2007;29(5):615-22.PMID:17654326
97) Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients.Bilgic A, Ozdemir FN, Bayraktar N, Karakus S, Sasak G, Arat Z, Sezer S, Haberal M. Am J Nephrol. 2007;27(4):366-72. Epub 2007 Jun 13. PMID:17570903
98) Adherence, depression and quality of life in patients on a renal transplantation waiting list. Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M.Transpl Int. 2007 Aug;20(8):682-7. Epub 2007 May 29.PMID:17535307
99) Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.Odabasi AR, Yuksel H, Karul A, Kozaci D, Sezer SD, Onur E.Saudi Med J. 2007 Jun;28(6):855-61.PMID:17530099100Pleural effusion in long-term hemodialysis patients.Bakirci T, Sasak G, Ozturk S, Akcay S, Sezer S, Haberal M.Transplant Proc. 2007 May;39(4):889-91.PMID:17524841
100) Factors associated with peak oxygen uptake in hemodialysis patients awaiting renal transplantation. Sezer S, Elsurer R, Ulubay G, Ozdemir FN, Haberal M.Transplant Proc. 2007 May;39(4):879-82. PMID:17524838
101) Increased body mass index is not a reliable marker of good nutrition in hemodialysis patients. Torun D, Micozkadioglu H, Torun N, Ozelsancak R, Sezer S, Adam FU, Ozdemir FN, Haberal M. Ren Fail. 2007;29(4):487-93.PMID:17497474
102) Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients.Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Ren Fail. 2007;29(3):285-8.PMID:17497441
103) Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?Afsar B, Sezer S, Elsurer R, Ozdemir FN.Blood Press Monit. 2007 Jun;12(3):133-9.PMID:17496462
104) Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.
Akgul A, Bilgic A, Sezer S, Ozdemir FN, Olcay I, Arat Z, Haberal M.Hemodial Int. 2007 Apr;11(2):198-203.PMID: 1740317110 6Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.Zumrutdal A, Ozer B, Singan M, Micozkadioglu H, Sezer S, Ozdemir FN, Haberal M.Ren Fail. 2007;29(1):85-90.PMID:17365915
105) Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study. Zumrutdal A, Baltali M, Micozkadioglu H, Torun D, Sezer S, Ozdemir FN, Haberal M.Ren Fail. 2007;29(1):67-71.PMID: 17365 912
106) Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids. Akman B, Uyar M, Afsar B, Sezer S, Ozdemir FN, Haberal M.Transplant Proc. 2007 Jan-Feb;39(1):135-7. PMID:17275490
107) Possible influence of vitamin D receptor gene polymorphisms on recombinant human erythropoietin requirements in dialysis patients.Sezer S, Tutal E, Bilgic A, Ozdemir FN, Haberal M.Transplant Proc. 2007 Jan-Feb;39(1):40-4.PMID:17275471
108) Relationship between depressive affect and malnutrition-inflammation complex syndrome in haemodialysis patients. Micozkadioglu H, Micozkadioglu I, Zumrutdal A, Erdem A, Ozdemir FN, Sezer S, Haberal M.Nephrology (Carlton). 2006 Dec; 11(6):502-5.PMID:17199787
109) Atherosclerosis in haemodialysis patients without significant comorbidities: determinants of progression. Zumrutdal A, Demircan S, Seydaoglu G, Singan M, Sezer S, Ozdemir FN, Haberal M.Nephrology (Carlton). 2006 Dec;11(6):489-93. PMID: 17199784
110) Effects of ACE gene polymorphism on vitamin D therapy according to parathyroid hormone level in patients on hemodialysis.Kulah E, Sezer S, Uyar M, Arat Z, Ozdemir FN. Adv Ther. 2006 Sep-Oct;23(5):778-86.PMID:17142213
111) Acute renal failure in intensive care unit: which factors predict future dialysis dependency? Elsürer R, Sezer S, Ozdemir NF, Akgul A, Arat Z, Haberal M.J Nephrol. 2006 Sep-Oct;19(5):634-9. PMID:17136693
112) Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients. Tutal E, Sezer S, Afsar B, Arat Z, Ozdemir FN, Haberal M.Transplant Proc. 2006 Nov;38(9):2807-12. PMID:17112835
113) Malnutrition-inflammation score is a useful tool in peritoneal dialysis patients. Afşar B, Sezer S, Ozdemir FN, Celik H, Elsurer R, Haberal M. Perit Dial Int. 2006 Nov-Dec;26(6):705-11. PMID:17047239
114) Respiratory evaluation of patients on continuous ambulatory peritoneal dialysis prior to renal transplantation.
Ulubay G, Sezer S, Ulasli S, Ozdemir N, Eyuboglu OF, Haberal M. Clin Nephrol. 2006 Oct;66(4):269-74. PMID:17063994
115) Effect of supportive extracorporeal treatment in liver transplantation recipients and advanced liver failure patients.
Ozdemir FN, Tutal E, Sezer S, Gür G, Bilgic A, Haberal M.Hemodial Int. 2006 Oct;10 Suppl 2:S28-32.PMID:17022748
116) Clinical outcome after transfer from peritoneal dialysis to hemodialysis. Bilgic A, Sezer S, Ozdemir FN, Akgul A, Arat Z, Haberal M. Adv Perit Dial. 2006;22:94-8.PMID: 16983948
117) 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients. Uyar M, Sezer S, Arat Z, Elsurer R, Ozdemir FN, Haberal M. Transplant Proc. 2006 Sep;38(7):2069-73. PMID:1698 0002
118) Reliability of mini nutritional assessment in hemodialysis compared with subjective global assessment. Afsar B, Sezer S, Arat Z, Tutal E, Ozdemir FN, Haberal M. J Ren Nutr. 2006 Jul;16(3):277-82. PMID:16825034
119) Prevalence and etiology of anemia in renal transplant recipients. Sezer S, Ozdemir FN, Tutal E, Bilgic A, Haberal M.
Transplant Proc. 2006 Mar;38(2):537-40. PMID:16549168
120) Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome. Sezer S, Akgul A, Altunoglu A, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2006 Mar;38(2):533-6
121) Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Sezer S, Bilgic A, Uyar M, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2006 Mar;38(2):529-32.PMID:16549166
122) Subjective global assessment is a useful method to detect malnutrition in renal transplant patients. Sezer S, Ozdemir FN, Afsar B, Colak T, Kizay U, Haberal M. Transplant Proc. 2006 Mar;38(2):517-20.PMID:16549164
123) De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Ozdemir BH, Ozdemir FN, Sezer S, Colak T, Haberal M. Transplant Proc. 2006 Mar;38(2):492-5.PMID:16549157
124) Does colchicine have an antifibrotic effect on development of interstitial fibrosis in renal allografts of recipients with familial Mediterranean fever? Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M. Transplant Proc. 2006 Mar;38(2):473-6.PMID:16549151
125) Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis.Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M. Transplant Proc. 2006 Mar;38(2):432-4. PMID:16549140
126) Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
Akman B, Afsar B, Ataç FB, Ibis A, Arat Z, Sezer S, Ozdemir FN, Haberal M. Transplant Proc. 2006 Mar;38(2):413-5.PMID:16549134
127) Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis.
Azap OK, Timurkaynak F, Sezer S, Cağir U, Yapar G, Arslan H, Ozdemir N. Transplant Proc. 2006 Mar;38(2):411-2.PMID:16549133
128) Hepatitis C infection in hemodialysis patients: Protective against oxidative stress? Sezer S, Tutal E, Aldemir D, Türkoglu S, Demirel OU, Afsar B, Ozdemir FN, Haberal M.Transplant Proc. 2006 Mar;38(2):406-10.PMID:16549132
129) Factors affecting exercise capacity in renal transplantation candidates on continuous ambulatory peritoneal dialysis therapy. Ulubay G, Akman B, Sezer S, Calik K, Eyuboglu Oner F, Ozdemir N, Haberal M. Transplant Proc. 2006 Mar;38(2):401-5. PMID:16549131
130) Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis. Karacan O, Tutal E, Colak T, Sezer S, Eyüboğlu FO, Haberal M. Transplant Proc. 2006 Mar;38(2):396-400.PMID:16549130
131) [Psychiatric problems, life quality and compliance in patients treated with haemodialysis and renal transplantation].
Sağduyu A, Sentürk VH, Sezer S, Emiroğlu R, Ozel S. Turk Psikiyatri Derg. 2006 Spring;17(1):22-31. Turkish. PMID:16528633
132) Doppler tissue imaging of the heart in secondary amyloidosis. Ulucam M, Yildirir A, Muderrisoglu H, Sezer S, Ozdemir N.Adv Ther. 2005 Sep-Oct;22(5):433-42.PMID:16418151
133) Is low blood magnesium level associated with hemodialysis headache? Goksel BK, Torun D, Karaca S, Karatas M, Tan M, Sezgin N, Benli S, Sezer S, Ozdemir N.Headache. 2006 Jan;46(1):40-5. PMID:16412150
134) Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients. Torun D, Oguzkurt L, Sezer S, Zumrutdal A, Singan M, Adam FU, Ozdemir FN, Haberal M. Perit Dial Int. 2005 Nov-Dec;25(6):596-600.PMID:16411528
135) The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Torun D, Sezer S, Arat Z, Pelit A, Yigit F, Ozdemir FN. Int Heart J. 2005 Nov;46(6):1073-82.
136) Frequency of atrial fibrillation and factors related to its development in dialysis patients. Atar I, Konaş D, Açikel S, Külah E, Atar A, Bozbaş H, Gülmez O, Sezer S, Yildirir A, Ozdemir N, Müderrisoğlu H, Ozin B. Int J Cardiol. 2006 Jan 4;106 (1):47-51.PMID:16321665
137) Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis. Zumrutdal A, Sezer S, Demircan S, Seydaoglu G, Ozdemir FN, Haberal M. Nephrology (Carlton). 2005 Oct;10(5):453-8. PMID:16221094
138) Risk factors for osteoporosis in young renal transplant recipients. Sezer S, Ozdemir FN, Ibis A, Sayin B, Haberal M.
Transplant Proc. 2005 Sep;37(7):3116-8.PMID: 16213324
139) Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal. Sezer S, Ozdemir FN, Elsurer R, Uyar M, Arat Z, Haberal M. Transplant Proc. 2005 Sep;37(7):2994-7. PMID:16213283
140) Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Sezer S, Uyar M, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2005 Sep;37(7):3109-11. PMID:16213322
141) Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, Sahin F, Haberal M. Transplant Proc. 2005 Sep;37(7):2922-4. PMID:16213262
142) Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M. J Ren Nutr. 2005 Oct;15(4):427-34. PMID:16198934
143) Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients. Ozdemir FN, Akçay A, Elsurer R, Sezer S, Arat Z, Haberal M. J Ren Nutr. 2005 Oct;15(4):371-6. PMID: 16198929
144) Amyloidosis: an infrequent cause of non-diabetic renal disease in patients with type 2 diabetes mellitus. Torun D, Bolat F, Sezer S, Ozdemir FN. Clin Nephrol. 2005 Sep;64(3):241-2. PMID: 16175951
145) Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M. Perit Dial Int. 2005 Feb;25 Suppl 3:S52-5. PMID:16048257
146) Weight gain after living-related renal transplantation affects long-term graft function. Micozkadioglu H, Ozdemir FN, Sezer S, Arat Z, Haberal M. Transplant Proc. 2005 Mar;37(2):1029-32. PMID:15848613
147) Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients. Sezer S, Uyar M, Akcay A, Arat Z, Kulah E, Ozdemir FN, Haberal M.
Transplant Proc. 2005 Mar;37(2):776-8. PMID:15848528
148) Association of cardiac valve calcification and inflammation in patients on hemodialysis. Torun D, Sezer S, Baltali M, Adam FU, Erdem A, Ozdemir FN, Haberal M. Ren Fail. 2005;27(2):221-6. PMID:15807189
149) A six-year follow-up after interferon-alpha monotherapy for chronic hepatitis C infection in hemodialysis patients.
Ozdemir FN, Akcay A, Sezer S, Boyacioglu S, Ozdemir BH, Arat Z, Haberal M. Ren Fail. 2004 Sep;26(5):583-8. PMID:155269 19
150) Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Sezer S, Akcay A, Ozdemir FN, Kulah E, Arat Z, Haberal M. Clin Transplant. 2004 Dec;18(6):722-5.PMID: 15516250
151) Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study. Micozkadioglu H, Ozdemir FN, Kut A, Sezer S, Saatci U, Haberal M. Ren Fail. 2004 Jul;26(4):393-7.PMID:15462107
152) Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Akcay A, Sezer S, Ozdemir FN, Arat Z, Atac FB, Verdi H, Colak T, Haberal M. Transplantation. 2004 Sep 27;78(6):892-8. PMID: 15385810
153) Pulmonary function in uremic patients on long-term hemodialysis. Karacan O, Tutal E, Uyar M, Eyüboğlu FO, Sezer S, Ozdemir FN. Ren Fail. 2004 May;26(3):273-8. PMID:15354977
154) Renal transplantation offers a better survival in HCV-infected ESRD patients. Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M. Clin Transplant. 2004 Oct;18(5):619-23. PMID:15344970
155) Effect of simvastatin in the treatment of highly sensitized dialysis patients: the pre and post-renal transplantation follow-up outcomes. Nurhan Ozdemir F, Akcay A, Sezer S, Arat Z, Colak T, Turan M, Gulmus S, Haberal M. Transpl Immunol. 2004 Jun-Jul;13(1):39-42. PMID:15203127
156) Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis.
Micozkadioğlu H, Colak T, Akçay A, Sezer S, Ataç FB, Verdi H, Arat Z, Ozdemir FN, Haberal M. Transplant Proc. 2004 Jan-Feb;36(1):161-3. PMID:15013333
157) The renin-angiotensin system and endothelial nitric oxide synthase gene polymorphisms and cyclosporine toxicity in renal transplant patients. Ozdemir FN, Miçozkadioğlu H, Ataç FB, Verdi H, Colak T, Ozdemir BH, Arat Z, Sezer S, Haberal M.
Transplant Proc. 2004 Jan-Feb;36(1):128-30. PMID: 15013322
158) Depression levels before and after renal transplantation. Akman B, Ozdemir FN, Sezer S, Miçozkadioglu H, Haberal M.
Transplant Proc. 2004 Jan-Feb;36(1):111-3.PMID:15013316
159) Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Sezer S, Ibiş A, Ozdemir BH, Ozdemir FN, Külah E, Boyacioğlu S, Haberal M. Transplant Proc. 2004 Jan-Feb;36(1):47-9. PMID:15013297
160) Clinical consequences of intermittent elevation of C-reactive protein levels in hemodialysis patients. Sezer S, Külah E, Ozdemir FN, Tutal E, Arat Z, Haberal M. Transplant Proc. 2004 Jan-Feb;36(1):38-40.PMID:15013294
161) Angiotensin-converting enzyme genotype is a predictive factor in the peak panel-reactive antibody response. Akçay A, Ozdemir FN, Ataç FB, Sezer S, Verdi H, Arat Z, Haberal M. Transplant Proc. 2004 Jan-Feb;36(1):35-7. PMID:15013293
162) Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates. Ozdemir FN, Sezer S, Akcay A, Arat Z, Turan M, Gulmus S, Kulah E, Haberal M.Transpl Immunol. 2004 Jan;12(2):185-8.PMID:14967317
163) Predictors of hematopoietic response after renal transplantation. Arat Z, Sezer S, Ozdemir FN, Uyar M, Turan M, Haberal M. Transplant Proc. 2003 Nov;35(7):2716-7..PMID:14612088
164) HCV antibody positivity significantly affects renal allograft survival. Ozdemir FN, Micozkadioglu H, Sezer S, Arat Z, Gürsoy M, Boyacioglu S, Haberal M.Transplant Proc. 2003 Nov;35(7):2701-2.. PMID: 14612081
165) Contribution of late acute rejection to long-term renal allograft survival in patients with chronic allograft nephropathy.
Sezer S, Ozdemir FN, Akcay A, Colak T, Kut A, Haberal M. Transplant Proc. 2003 Nov;35(7):2637-8..PMID: 14612049
166) Assessment of risk factors for chronic allograft nephropathy in renal transplant patients. Sezer S, Ozdemir FN, Agca E, Colak T, Arat Z, Haberal M. Transplant Proc. 2003 Nov;35(7):2634-6..PMID:14612048
167) Do serum albumin and aminotransferase levels predict renal graft outcome: a 5-year follow-up. Sezer S, Ozdemir FN, Külah E, Colak T, Turan M, Haberal M. Transplant Proc. 2003 Nov;35(7):2607-8. PMID:14612037
168) Influence of recipient family history of atherosclerosis of renal allograft outcome. Ozdemir FN, Cantürk F, Colak T, Sezer S, Agca E, Haberal M. Transplant Proc. 2003 Nov;35(7):2602-4. PMID:14612035
169) Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients.Sezer S, Ozdemir FN, Arat Z, Turan M, Haberal M. Nephron. 2002 Jul;91(3):456-62.PMID:12119477
170) Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M. Artif Organs. 2002 Apr;26(4):366-70.PMID:11952508
171) The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients.
Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M. Ren Fail. 2002 Jan;24(1):37-48.PMID:11921697
172) The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients.
Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M. Ren Fail. 2002 Jan;24(1):37-48.PMID:11921697
173) Spectrum of liver damage and correlation with clinical and laboratory parameters in HCV infected hemodialysis patients. Sezer S, Ozdemir BH, Arat Z, Turan M, Ozdemir NF, Haberal M. Ren Fail. 2001 Nov;23(6):807-18.PMID:11777320
174) Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis. Sezer S, Ozdemir FN, Akman B, Arat Z, Anaforoglu I, Haberal M. Adv Perit Dial. 2001;17:210-4.PMID:11510278
175) The effect of simvastatin on panel-reactive antibody and crossmatch positivity.Ozdemir FN, Sezer S, Turan M, Colak T, Arat Z, Gülmüş S, Haberal M. Transplant Proc. 2001 Aug;33(5):2842-3. No abstract available. PMID:11498182
176) Ferritin levels can be a good predictor for HCV viremia in potential renal transplant candidates. Sezer S, Ozdemir FN, Güz G, Ozdemir BH, Sengül S, Arat Z, Turan M, Demirhan B, Haberal M. Transplant Proc. 2001 Aug;33(5):2796-8. No abstract available. PMID:11498163
177) Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients.
Ozdemir FN, Güz G, Sezer S, Arat Z, Turan M, Haberal M.Artif Organs. 2001 Jun;25(6):448-52 PMID:11453874
178) Is hepatitis C virus infection a risk factor for panel-reactive antibody positivity? Ozdemir FN, Sezer S, Güz G, Arat Z, Turan M, Haberal M. Transpl Int. 2000;13 Suppl 1:S31-3.PMID:11111957
179) What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
Sezer S, Ozdemir N, Arat Z, Güz G, Sengül S, Akman B, Haberal A, Turan M, Haberal M.Adv Perit Dial. 2000;16:177-81. PMID: 11045288
180) High frequency of amyloid lymphadenopathy in uremic patients. Güz G, Ozdemir BH, Sezer S, Yakupoglu U, Demirhan B, Ozdemir FN, Haberal M.Ren Fail. 2000;22(5):613-21. PMID: 11041293
181) Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
Güz G, Nurhan Ozdemir F, Sezer S, Işiklar I, Arat Z, Turan M, Haberal M. Am J Kidney Dis. 2000 Oct;36(4):826-36.PMID: 11007687
182) Ambulatory blood pressure monitoring in potential renal transplant donors. Ozdemir FN, Güz G, Sezer S, Arat Z, Haberal M. Nephrol Dial Transplant. 2000 Jul;15(7):1038-40.PMID:10862644
183) Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Sezer S, Ozdemir FN, Güz G, Arat Z, Colak T, Sengul S, Turan M, Haberal A, Erdal R. Transplant Proc. 2000 May;32(3):607-8. PMID:10812136
184) Anticardiolipin antibodies in hemodialysis patients. Ozdemir N, Güz G, Sezer S, Haberal A, Ayaz H, Haberal M.
Transplant Proc. 1999 Dec;31(8):3388-9..PMID:10616518
185) Tumor markers in hemodialysis patients. Arican A, Ozdemir N, Sezer S, Erten Y, Güz G, Turan M, Inanoglu I, Haberal M.Transplant Proc. 1999 Dec;31(8):3367-8. PMID:10616509
186) Immunologic profile of end-stage renal failure patients. Sezer S, Ozdemir N, Güz G, Turan M, Arslan S, Haberal M.
Transplant Proc. 1999 Dec;31(8):3359-60. MID:10616506
187) Zinc deficiency: prevalence and causes in hemodialysis patients and effect on cellular immune response. Erten Y, Kayataş M, Sezer S, Ozdemir FN, Ozyiğit PF, Turan M, Haberal A, Güz G, Kaya S, Bilgin N. Transplant Proc. 1998 May;30(3):850-1. PMID:9595125
188) Prevalence of serological markers of autoimmunity in hemodialysis patients with hepatitis C virus. Ozdemir FN, Turan M, Sezer S, Kayataş M, Haberal A, Güz G, Erten Y, Hizel N, Boyacioğlu S, Gülmüş S, Bilgin N. Transplant Proc. 1998 May;30(3):848-9. PMID:9595124
189) Tuberculosis remains an important factor in the morbidity and mortality of hemodialysis patients. Ozdemir FN, Güz G, Kayataş M, Sezer S, Arslan H, Turan M.Transplant Proc. 1998 May;30(3):846-7. PMID:9595123
190) Comparison of panel reactive antibody levels with clinical and laboratory parameters in end-stage renal disease patients. Sezer S, Ozdemir FN, Turan M, Güz G, Haberal A, Kaya S, Bilgin N. Transplant Proc. 1998 May;30(3):844-5. No abstract available. PMID:9595122

7.2. Articles published in other international peer-reviewed journals
1) Peritonitis due to Streptococcus anginosus in patients treated with CAPD: a report of two cases. Ibis A, Sezer S, Tutal E, Azap OK, Ozdemir FN. Perit Dial Int. 2008 May-Jun;28(3):315-6.
2) Gastric carcinoid tumour: occurrence in a systemic lupus erythematosus patient with end-stage renal disease. Usluogullari AC, Afsar B, Elsurer R, Ozdemir HB, Sezer S, Ozdemir NF. Lupus. 2007;16(7):537-8. No abstract available. PMID: 17670856
3) Does Helicobacter pylori play a role in nocturnal non-dipping? Afsar B, Elsurer R, Karacan O, Sezer S. Med Hypotheses. 2007;69(6):1382-3. Epub 2007 May 4. No abstract available. PMID:17482373
4) Helicobacter pylori infection may increase renal resistive index. Afsar B, Ozdemir FN, Elsurer R, Sezer S. Med Hypotheses. 2007;69(4):956-7. Epub 2007 Mar 19. No abstract available. PMID:17368955
5) Mixed connective tissue disease: a case with scleroderma renal crisis following abortion. Celikbilek M, Elsurer R, Afsar B, Ozdemir HB, Sezer S, Ozdemir NF. Clin Rheumatol. 2007 Sep;26(9):1545-7. Epub 2006 Nov 21. PMID:17119864
6) Acute tubulointerstitial nephritis and acute leukemia: report of 2 cases. Elsurer R, Afsar B, Ozdemir HB, Ozdemir NF, Sezer S, Haberal M. J Nephrol. 2006 Jul-Aug;19(4):521-4. PMID:17048212
7) Isolated Brucella peritonitis in a CAPD patient. Ozisik L, Akman B, Huddam B, Azap OK, Bilgic A, Sezer S, Ozdemir N.
Am J Kidney Dis. 2006 May;47(5):e65-6. PMID:16632008
8) Report of a case with surprising etiology of renovascular hypertension. Zumrutdal A, Tercan F, Oguzkurt L, Sezer S, Nurhan Ozdemir F. Clin Nephrol. 2005 Dec;64(6):444-7. PMID:16370157
9) Seronegative systemic lupus erythematosus: etiology of nephrotic syndrome and acute renal failure in early postpartum period. Ozdemir FN, Elsurer R, Akcay A, Ozdemir BH, Sezer S, Kuscu E, Haberal M. Lupus. 2005;14(8):629-31. PMID:16175936
10) Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren's syndrome. Adam FU, Torun D, Bolat F, Zumrutdal A, Sezer S, Ozdemir FN. Clin Rheumatol. 2006 Feb;25(1):75-9. Epub 2005 May 26. PMID:15917985
11) Gemella morbillorum peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis. Azap OK, Yapar G, Timurkaynak F, Arslan H, Sezer S, Ozdemir N. Nephrol Dial Transplant. 2005 Apr;20(4):853-4. No abstract available.
PMID:15772279
12) Neutropenia due to clopidogrel in a patient with end-stage renal disease. Akcay A, Kanbay M, Agca E, Sezer S, Ozdemir FN. Ann Pharmacother. 2004 Sep;38(9):1538-9. Epub 2004 Aug 3. No abstract available.PMID:15292496 13) Acute interstitial nephritis due to cefoperazone.
Torun D, Sezer S, Kayaselcuk F, Zumrutdal A, Ozdemir FN, Haberal M. Ann Pharmacother. 2004 Sep;38(9):1446-8. Epub 2004 Jun 22. PMID:15213314
14) Acute renal failure and hepatotoxicity associated with roxithromycin. Akcay A, Kanbay M, Sezer S, Ozdemir FN.
Ann Pharmacother. 2004 Apr;38(4):721-2. Epub 2004 Feb 6. No abstract available.PMID:14766998

Academic Activities

Başkent University Nephrology Head of Department (2014-2017)
Başkent University Dialysis Vocational School Founder and Head of Department (2010-)
Turkish Nephrology Association member of the Board of Directors (2017- )
European Dialysis Transplantation Association Outstanding Member (since 2012) (ERA-EDTA FERA)
International Society of Nephroloji-Educational Ambassador, 2010-
Education envoi of International Nephrology association in 3 centers of Azeribaijan, Baku - Sept 2012 (one week)
European Nephrology Association Nutrition senior committee member
(ERA EDTA Nutrition board) (since December 2014 )
Nephrology Associatiopn uremic bone diseases group senior committee member
Turkish Nephrology Association Nutrition group senior committee member
Turkish Nephrology Association Ankara Branch member
KEPAN Nephrology Association senior committee member (new activity)
Turkish Nephrology Association scientific senior committee member

Congresses

2015 – Turkish Nephrology Association, 32nd National Nephrology, hypertension, dialysis and transplantation congress scientific secretary (Oct 21-25)

2016 – Turkish Nephrology Association, 33rd National Nephrology, hypertension, dialysis and transplantation congress scientific secretary (Oct 19-23)Turkish Azeribaijan Nephrology Congress scientific secretary (Oct 2015)

2017 - Third International ERA EDTA, European Nephrology Association nutrition course organizer (Oct 18-19, Antalya)Tasks by Ministry of Health: 2014 – 2017 Preventive group chairman in chronic kidney disease prevention program Educator in “peritoneal dialysis in chronic kidney failure” workshopCoordinator in Ministry of Health Chronic Diseases Department Hypertension follow-up guidance

(2017-2018) Educator trainings in Ministry of Health Chronic Diseases (Hypertension Oct-Dec 2017- 3 groups)

Chronic Renal Failure Prevention Program training set preparation responsible faculty member (2018 July – cont.)